Gyre Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Gyre Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Gyre Therapeutics Inc
Rating: 2.299541625
Author: Trendlyne DVM scores

Mid-range Performer

about

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-sta...

7.85 -0.20 (-2.48%)

42.78% Fall from 52W High

65,577

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Medium Financial Strength

50.0 / 100

Mid Valuation

31.3 / 100

Technically Neutral

52.6 / 100

Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM

1Yr Price target upside is 129%

3 analysts

Gyre Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Gyre Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-sta...

42.78% Fall from 52W High

SWOT Analysis

Gyre Therapeutics Inc Live Price Chart